Portfolio company
CereVasc
United States · £34.7m raised
Raised
£34.7m
Latest stage
Series A
Rounds recorded
1
Backed by
2 investors
Sectors
About
This medical device company develops a minimally invasive endovascular shunt system to treat patients suffering from communicating hydrocephalus and other neurological brain disorders.
SourceFunding history · 1
Similar companies
NeuroBionics
This company develops flexible bioelectronic fibers for endovascular neuromodulation to treat neurological and peripheral nerve disorders in patients without requiring invasive open-brain surgery.
Madison Scientific
This company develops implantable electromechanical shunt systems to manage cerebrospinal fluid drainage for patients suffering from hydrocephalus and other neurologic conditions.
Vonova
This medical technology company develops an endovascular platform that enables clinicians to access the brain via the venous system to treat chronic neurological conditions.
EnClear Therapies
The company develops a drug delivery system for the cerebrospinal fluid to treat patients with neurological diseases and brain tumours.
Neurobioniocs
The company develops flexible bioelectronic fibers that deliver neuromodulation therapy through blood vessels for patients with neurological disorders.
MicroVention
The company develops and manufactures minimally invasive neuroendovascular medical devices to help surgeons treat cerebrovascular diseases and vascular disorders in the brain.
Neuraworx
This company develops a wearable neurostimulation device that enhances the brain's waste clearance system to treat neurodegenerative diseases and traumatic brain injuries.
Artiria Medical
The company develops deflectable guidewires for neurovascular procedures to help surgeons navigate complex brain arteries during stroke and aneurysm treatments.
